The director of Oregon Health & Science University’s $1 billion Knight Cancer Institute resigned this week after just one year on the job, leaving OHSU with yet another interim leader in a key role.

The CEO of OHSU’s Knight Cancer Institute is stepping down. On Tuesday, Dr. Brian Druker announced his resignation. Druker developed a revolutionary drug to treat cancer. In a letter to ...

Druker is still at OHSU, now as the CEO of the Knight Cancer Institute. With Gleevec, he found a way to give thousands of people a new lease on life. He joked with Dooris that he now tells ...

Dr. Tom Sellers, who has served as director of the OHSU Knight Cancer Institute for the past year, has resigned. Sellers took the reins of the institute last March, when Dr. Brian Druker changed r ...

The website you are visiting is protected and accelerated by Imperva. Your computer may have been infected by malware and ...

Harvard no longer has a primate research center. But in 2009, Harvard’s Wyss Institute for Biologically Inspired Engineering ...